Catecholamine reuptake inhibitor: Difference between revisions

Revision as of 05:06, 25 June 2006 editArcadian (talk \| contribs)163,050 edits stub		Revision as of 13:28, 2 September 2006 edit undoAspro (talk \| contribs)Extended confirmed users, Pending changes reviewers10,326 edits added citeNext edit →
Line 4:		Line 4:
	* ]		* ]

	An example is ].		An example is ].<ref>{{cite paper
			\| author =Stephen M. Stahl, M.D., Ph.D.; et al
			\| title =A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor
			\| publisher =Journal of Clinical Psychiatry; 6(04) 159-166 2004 ''PHYSICIANS POSTGRADUATE PRESS, INC''
			\| date = 2004
			\| url = http://www.psychiatrist.com/pcc/pccpdf/v06n04/v06n0403.pdf
			\| format = pdf
			\| accessdate =2006-09-02 }}</ref>


	{{treatment-stub}}		{{treatment-stub}}

	{{Antidepressants}}		{{Antidepressants}}
			==References==
			<references />

Revision as of 13:28, 2 September 2006

A Norepinephrine-dopamine reuptake inhibitor is a class of drugs that is both:

An example is Bupropion.

This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it.

SSRIsTooltip Selective serotonin reuptake inhibitors	Citalopram Escitalopram Fluoxetine Fluvoxamine Indalpine Paroxetine Sertraline Zimelidine
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors	Desvenlafaxine Duloxetine Levomilnacipran Milnacipran Tofenacin Venlafaxine
NRIsTooltip Norepinephrine reuptake inhibitors	Atomoxetine Reboxetine Viloxazine
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors	Amineptine Bupropion Nomifensine
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants	Mianserin Mirtazapine Setiptiline
SARIsTooltip Serotonin antagonist and reuptake inhibitors	Etoperidone Nefazodone Trazodone
SMSTooltip Serotonin modulator and stimulators	Vilazodone Vortioxetine
Others	Agomelatine Amisulpride Dextromethorphan/bupropion Esketamine Etryptamine Gepirone Indeloxazine Flupentixol Ketamine Medifoxamine Metryptamine Oxaflozane Pivagabine Tandospirone Teniloxazine Tianeptine

TCAsTooltip Tricyclic antidepressants	Amineptine Amitriptyline Amitriptylinoxide Amoxapine Butriptyline Clomipramine Demexiptiline Desipramine Dibenzepin Dimetacrine Dosulepin Doxepin Imipramine Imipraminoxide Iprindole Lofepramine Melitracen Metapramine Nitroxazepine Nortriptyline Noxiptiline Opipramol Pipofezine Propizepine Protriptyline Quinupramine Tianeptine Trimipramine
TeCAsTooltip Tetracyclic antidepressants	Maprotiline Mianserin Mirtazapine Setiptiline
Others	Tiazesim

Non-selective

MAO_ATooltip Monoamine oxidase A-selective

MAO_BTooltip Monoamine oxidase B-selective

Adjunctive therapies
Atypical antipsychotics (aripiprazole, brexpiprazole, lurasidone, olanzapine, quetiapine, risperidone) Buspirone Lithium (lithium carbonate, lithium citrate) Thyroid hormones (triiodothyronine (T₃), levothyroxine (T₄))

Miscellaneous
Ademetionine (SAMe) GABAkine neurosteroids (brexanolone, zuranolone) Hypericum perforatum (St. John's Wort) Oxitriptan (5-HTP) Rubidium chloride (RbCl) Tryptophan

Stephen M. Stahl, M.D., Ph.D.; et al. (2004). "A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor" (pdf). Journal of Clinical Psychiatry; 6(04) 159-166 2004 PHYSICIANS POSTGRADUATE PRESS, INC. Retrieved 2006-09-02. {{cite journal}}: Cite journal requires |journal= (help); Explicit use of et al. in: |author= (help); Italic or bold markup not allowed in: |publisher= (help)CS1 maint: multiple names: authors list (link)